Treatment continuation depends on your clinical response and ongoing need for glucose control, not an arbitrary time limit
Zepbound), the SURPASS-2 trial compared tirzepatide to a lower dose of semaglutide in patients with type 2 diabetes
La decisin sobre la mejor alternativa debe individualizarse considerando el perfil clnico completo del paciente, preferencias personales, cobertura de seguro, y objetivos teraputicos especficos
15 Elderly population Efficacy and safety of semaglutide across the SUSTAIN program (15 trials) in people younger and older than 65 years have been compared in a post hoc analysis
Skip the adjustment period, and you are looking at nausea, vomiting, and GI distress that can derail your protocol before it even begins
This impacts your blood sugar levels and the effectiveness of the medication